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 Syndrome-based diagnostic approach
 Respiratory tract infections 
 Take home messages
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Infectious diseases in the XXIst century: 
Burden, threats and challenges
INTRODUCTION
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Causes of mortality (WHO 2008)
Global death rate 
related to infections 
= 20-25%
INFECTIONS 
= second cause 
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Causes of mortality (WHO 2008)
Low income countries 
(Africa, Asia, …) death rate 
related to infections 
= 40%
INFECTIONS 
= first cause 
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« Top » of deadly infectious
diseases, WHO 2008
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« Top » of deadly infectious
diseases, WHO 2008
8Coris Workshop 29.09.2015- PMelin – CHULg
Worldwide major threat: 
Bacteria are doing resistance
Global increase of antimicrobial resistance 
Emerging superbug
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Introduction
Fundamental to quality care
 Rapid and accurate establishment of a microbial cause
 Whether caring for individual patients with infectious disease
 Or responding to a worlwide pandemic
 To facilitate stewardship for rational use of 
antimicrobial agents when needed
 ….
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Clinical microbiology laboratory
Primary missions
TO IMPROVE THE MANAGMENT OF INFECTIOUS DISEASE
CONTRIBUTION TO DIAGNOSTIC
Presence /absence of pathogens
Identification +/- quantification
Bacteria, fungi, virus, parasites 
CONTRIBUTION  TO CHOICE OF ANTIBIOTHERAPY
Probabilistic, targeted
Antimicrobial susceptibility testing, identification of resistance 
mechanisms and resistance genes
SUPPORT TO INFECTION CONTROL
To provide useful, accurate and relevant results
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« Useful » results
POSITIVE IMPACT ON
 Therapeutic decision?
 Optimized management of patients?
 Morbidity, mortality?
 Length of hospitalization?
Reduction of Turn-Around-Time 
for result and its notification to clinician
 Control of nosocomial infections?   
 Antibiotic consumption?
 Control of antimicrobial resistance? 
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XXIst century 
Medical evolutionary background
Factors impacting on development and daily 
practice of microbiology
 Economic environment
 Cost-effective use of available resources
 Reimbursement system, regulation 
 Trained human resources
 Population pyramid and labour shortage
 Medical environment
 Increasing emphasis on evidence-based medicine 
and adherence to guidelines
 Technological background
 Exponential progress: molecular biology and robots
 Quality assurance, traceability
 Global increase of antimicrobial resistance 
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Reduction of time for microbial detection 
and identification
“NEED FOR SPEED” 
Desirable improvement
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Theranostic approach
« Process of diagnostic therapy for individual patients »
Turnaround time












Delayed results are unhelpful for clinicians !
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Rapid identification of a pathogen
Prime importance for effective provision of care 
to patients with infections
The faster you identify pathogens,
the quicker you can react to it, implementing
 Treatment 
 Preventive measures and control of infections
Benefits are also  for
The community, hospital and control measures
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Microbiological diagnostics of 
syndromic diseases
 Syndromic diseases
 Characterized by the abnormal presence, 
simultaneously, of a group of signs and symptoms
 Respiratory tract infections 
• Pneumonia, bronchiolitis, sore throat, etc.
 Gastro-enteritis
 Sexually transmitted diseases
 Etc.
Bacteria, fungi, viruses, parasites
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Microbiological diagnostic approaches
 Conventional (aetiological) approach
 « Is a specific pathogen present in the specimen? »
 Step by step, on demand (primarily directed to typical bacteria) 
 Varied individual methods
 TAT : minutes to days or even weeks
 Syndrome-based approach
 « Which pathogen is causing this syndrome? »
 Broad panel diagnostic method (Including atypical agents, 
viruses, fungi, parasites)
 All inclusive testing system
 TAT : hour(s)
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Point of-care-test platforms for early
diagnosis of infection
To provide an integrated, holistic solution addressing 
technological challenges
 For rapid increased detection of bacteria, mycobacteria, fungi, 
viruses, host markers and resistance to antimicrobial drugs
 To enhance clinical decision-making
 To improve quality of care and clinical outcomes
 To improve targeted therapy and reduce overuse 
 Specific probes
 Novel methods of sample preparation
 Ultra-high sensitive detection methods
Results availability 
in less than 2 hours/ 30 min for IN/OUT patients 
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Point of-care-test platforms for early
diagnosis of infection
To provide an integrated, holistic solution addressing 
technological challenges
 For rapid detection of bacteria, mycobacteria, fungi, viruses, host 
markers and resistance to antimicrobial drugs
 To enhance clinical decision-making
 To improve quality of care and clinical outcomes
 To improve targeted therapy and reduce overuse 
 Specific probes
 Novel methods of sample preparation
 Ultra-high sensitive detection methods
Results availability 
in less than 2 hours/ 30 min for IN/OUT patients 
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Current diagnostic landscape , 
unmet needs and emerging technologies
LOWER RESPIRATORY TRACT 
INFECTIONS
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Aetiological agents of LRTI in the 
community (%)
Woodhead M et al. Clin. Microbiol.Infect. 2011; 17, E1-E59
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Conventional diagnostic methods
 Direct microscopy - Gram stain
 For detection of S.pneumoniae, H.influenzae
 Low Sensitivity ang NPV
 High specificity and PPV
 Quality control of sputum sample
Old, simple, cheap & rapid diagnostic test for pneumonia
Helps in guiding antibiotic treatment in +/- 25% of 
patients 
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Conventional culture-based methods
(addressed mainly to Bacteria)
 Value of sputum cultures
 Good Sensitivity ang NPV, if predominant morphotype
 Low specificity and PPV, due to contamination 
 except for bacteria not part of normal flora (eg. Legionella, 
M.tuberculosis)
 Relevant for colonizing organisms: if correlated with
predominant organisms identified on Gram stain
 Value of blood cultures in the diagnosis of CAP
 Specificity : very high (100%)
 Sensitivity : low, positive in 4-29% of untreated cases
 Most sensitive for S.pneumoniae, less for H.influenzae and 
other pathogens
 But... easy to sample and often the only source of information! 
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Conventional diagnostic methods
Rapid Antigen testing for LRTI
 Urinary antigen tests
 Legionella pneumophila serogroupe 1
 Streptococcus pneumoniae
(not in children)
 Antigen tests for respiratory specimens





Sensitivity depends on specimen type, sampling method and 
microscopist’s competence
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Diagnostic tests for Legionella
Limited to L.pneumophila serogroup1
Ag L.pneumophila Positive influence on management, correct treatment
immediately started but many drawbacks
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Conventional diagnostic methods
Rapid Antigen testing for LRTI
 Urinary antigen tests
 Legionella pneumophila serogroupe 1
 Streptococcus pneumoniae
 Antigen tests for respiratory specimens (single 
or pooled)





Sensitivity depends on specimen type, sampling method and 
microscopist’s competence or other immuno-assay methods
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Molecular diagnostic methods
Choice of platforms and assays
 Commercial versus « in house tests »
 Degree of validation and standardization
 Variability between laboratories
 Internal controls
 Quantification standards
 Requirements ISO 15189
 Mainly for viral, atypic bacterial and fungal
targets
 Qualitative test
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From Pr. Greet Ieven
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From Pr. Greet Ieven Biofire (bioMerieux)
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Multiplex  all inclusive tests and 
system
GenMark Diagnostics




• 3 1⁄2 hours
Curetis Univero system
Pneumonia panel: 16 bacteria + 1 
Fungus and 22 antibiotic resistance 
markers 
 Endpoint PCR 
 Array format 
 4 hours 
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C4L platform Coris (EU funded project)
 C4L Prototype
 Influenza A, Influenza B, RSV A, RSV B, Human
metapneumovirus, Rhinovirus
 Bordetella pertussis, Mycoplasma pneumoniae
 C4L Prototype compared with the RespiFinder
2SMART assay
 In CHU Liège
 Broncho alveolar lavages (adults) and nasopharyngeal
aspirates (mixed population)
 82 % agreement
 In UZ Antwerpen
 Mainly nasopharyngeal aspirates (children)
 84 % agreement
P.Melin University Hospital of Liege
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C4L platform Coris (EU funded project)
 C4L Prototype
 Influenza A, Influenza B, RSV A, RSV B, Human
metapneumovirus, Rhinovirus
 Bordetella pertussis, Mycoplasma pneumoniae
 C4L Prototype compared with the RespiFinder
2SMART assay
 Lack of sensitivity
 for Rhinovirus
 In mixed infection 
 Improved rate of detection of clinically significant
pathogens when compared to conventional approach
 For viral and atypical targets
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Mutations & a new culture are necessary to enjoy over the future 
of microbiology
Multiplex syndromic approach
 Reduction of TAT
 Increased rate of detection for a wide panel of aetiological
agents
 Improved management of patients with severe infections
 Initiation more rapidly the appropriate rational use of 
antibiotics
 Avoidance of unnecessary antibiotherapy
 Cost avoidance
 Implementation of control measures for contagious agents
 Complementary to conventional methods
 C4L prototype platform and chips  
 Could be used in the lab as a POCT
